NEW YORK, June 30, 2015 – Arsenal Capital Partners today announced the acquisition of Peach State Labs, Inc. (“Peach State Labs” or the “Company”), a leading provider of specialty polymers and chemicals.
Founded in 1987 and headquartered in Rome, Georgia, Peach State Labs is a technology driven developer of a variety of specialty polymers and other unique chemicals to a number of end markets, including flooring, textiles, coatings & paints, consumer products, leather, institutional water treatment, and lubricants.
John Televantos, a Partner who co-heads Arsenal’s Specialty Industrials group, said, “Peach State Labs has a long history of innovation in the polymers sector providing unique formulations and solutions to its diverse customers and their applications. The acquisition of Peach State Labs represents a niche platform in our strategy to build a global polymers business offering customized and proprietary solutions.”
Rick Sargent, founder and CEO of Peach State Labs, said, ”Over the last three decades, we have built a business that consistently innovates chemical technologies and solutions to address our customers’ needs and the evolving trends in their end markets. We chose Arsenal Capital as our partner as we believe they are uniquely capable of supporting the Company’s continued growth in existing and new markets.”
“We look forward to partnering with Rick, the management and employees of Peach State Labs to expand the strong platform they have successfully built. The company has built a brand name and reputation in the specialty polymers sector, and we will further expand on this through organic growth initiatives and additional acquisitions. Our goal is to build one of the largest global specialty polymer solutions suppliers,” added Sal Gagliardo an Operating Partner in Arsenal’s Specialty Industrials group.
The acquisition of Peach State Labs represents the ninth platform acquisition in Arsenal Capital Fund III LP with $875 million of committed capital.
CIM Partners acted as financial advisor to Peach State Labs.
About Arsenal Capital Partners
Arsenal Capital Partners is a leading New York-based private equity firm that invests in lower middle market healthcare and specialty industrial companies. Arsenal makes investments in sectors where the firm has significant prior knowledge and experience. Arsenal targets businesses that have the potential for further value creation by working closely with management to accelerate growth and leverage the firm’s operational improvement capabilities. Arsenal currently has $1.7 billion of committed equity capital. For additional information on Arsenal Capital Partners, please visit www.arsenalcapital.com.
Arsenal’s Specialty Industrials investments includes several market leaders including Kel-Tech, a leading provider of specialty chemicals and related services to oil & gas exploration and production companies; Flowchem, a leading provider of patented and environmentally friendly drag reducing additive solutions and support services to crude oil and refined products pipeline operators; Accella Performance Materials, a leading manufacturer of formulated polyurethane, specialty coatings as well as recycled rubber products; Chromaflo Technologies, the largest independent global pigment dispersion provider to the architectural and industrial coatings and thermoset composites industries; Inhance Technologies, a leading provider of unique plastic barrier, adhesion and surface enhancement products and services as well as manufacturer of value-added materials; International Fiber Corporation, a leading provider of dietary insoluble fiber for food and pharmaceutical markets; and IGM Resins, a leading provider of intermediates to the global ultraviolet radiation cure coatings, inks and adhesives industry.